Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Andrew L. Wilson, PharmD, FASHP, Vice President, McKesson 340B Solutions
Articles
Understanding and Navigating Specialty and Orphan Drug Challenges in the 340B Program
Lisa Nezneski, PharmD, BCPS, Managing Consultant, McKesson 340B Solutions;Christopher S. Shain, PharmD, BCPS, Assistant Vice President, McKesson 340B Solutions;Andrew L. Wilson, PharmD, FASHP, Vice President, McKesson 340B Solutions
March 15th 2019Failure to recognize the interests of manufacturers to ensure proper use of 340B pricing may result in 340B hospitals missing the opportunity to secure and retain discounts on key orphan and specialty drugs or may render them unable to access the drugs at all.
Read More
Latest Updated Articles
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Published: December 17th 2024 | Updated: December 22nd 2024
Sacituzumab Govitecan-hziy Receives FDA Breakthrough Therapy Designation for Extensive-Stage Small Cell Lung Cancer Treatment
Published: December 19th 2024 | Updated: December 22nd 2024
FDA Accepts Biologics License Application for Clesrovimab to Protect Infants from RSV Infection
Published: December 13th 2024 | Updated: December 22nd 2024
ASHP Midyear: Pharmacists Play Key Role in Addressing Depression in Women Through Medication Management
